Gastrointestinal stromal tumours can express CD10 and epithelial membrane antigen but not oestrogen receptor or HMB45

Histopathology

Volumn 59, Issue 4, 2011, Pages 781-785

  Wong, Newton A C S ^a   Melegh, Zsombor ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

CD10; EMA; Gastrointestinal stromal tumour; HMB45; Immunohistochemistry; Melan A

Indexed keywords

CD103 ANTIGEN; CELL PROTEIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR ALPHA; PROTEIN HMB45; UNCLASSIFIED DRUG;

ARTICLE; CELL TYPE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SPINDLE CELL; TISSUE MICROARRAY;

ESTROGEN RECEPTOR ALPHA; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA-SPECIFIC ANTIGENS; MUCIN-1; NEPRILYSIN; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80054913507     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03979.x     Document Type: Article

References (29)

1. Rutkowski P, Debiec-Rychter M, Ruka W. Gastrointestinal stromal tumors: key to diagnosis and choice of therapy. Mol. Diagn. Ther. 2008; 12; 131-143.
2. Schildhaus HU, Cavlar T, Binot E et al. Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J. Pathol. 2008; 216; 176-182.
3. Garrido MC, Bastian BC. KIT as a therapeutic target in melanoma. J. Invest. Dermatol. 2010; 130; 20-27.
4. Miettinen M, Wang Z-F, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors. A study of 1840 cases. Am. J. Surg. Pathol. 2009; 33; 1401-1408.
5. Wong NACS, Melegh Z. Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry. Histopathology 2009; 54; 529-536.
6. Folpe AL, Mentzel T, Lehr HA et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am. J. Surg. Pathol. 2005; 29; 1558-1575.
7. Fisher C, de Bruijn DRH, Geurts van Kessel A. Synovial sarcoma. In Fletcher CDM, Unni KK, Mertens F eds. World Health Organization classification of tumor. Pathology and genetics. Tumours of soft tissue and bone. Lyon: IARC Press, 2002; 200-204.
8. Shidham VB, Chivukula M, Gupta D, Rao RN, Komorowski R. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch. Pathol. Lab. Med. 2002; 126; 1189-1192.
9. Miettinen M, Furlong M, Sarlomo-Rikala M et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am. J. Surg. Pathol. 2001; 25; 1121-1133.
10. Nga ME, Wong AS, Wee A, Salto-Tellez M. Cytokeratin expression in gastrointestinal stromal tumours: a word of caution. Histopathology 2002; 40; 480-481.
11. Rossi G, Sartori G, Valli R et al. The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour. J. Clin. Pathol. 2005; 58; 991-993.
12. Lippai N, Füle T, Németh T et al. Keratin-positive gastrointestinal stromal tumor of the stomach mimicking gastric carcinoma: diagnosis confirmed by c-kit mutation analysis. Diagn. Mol. Pathol. 2008; 17; 241-244.
13. Suárez-Vilela D, Izquierdo-García FM. Cytotoxic T-lymphocyte-rich, gastrointestinal stromal tumour. Histopathology 2003; 43; 398-410.
14. Jungbluth AA, Busam KJ, Gerald WL et al. A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am. J. Surg. Pathol. 1998; 22; 595-602.
15. Dal Corso HM, Solej M, Nano M. Giant gastrointestinal stromal tumor of the stomach in an elderly patient. J. Gastrointest. Surg. 2007; 11; 804-806.
16. Aoyama T, Saeki H, Samejima J et al. A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate. Gan. To. Kagaku. Ryoho. 2009; 36; 975-978.
17. Guler ML, Daniels JA, Abraham SC, Montgomery EA. Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall. Arch. Pathol. Lab. Med. 2008; 132; 1302-1306.
18. Wingen CB, Pauwels PA, Debiec-Rychter M, van Gemert WG, Vos MC. Uterine gastrointestinal stromal tumour (GIST). Gynecol. Oncol. 2005; 97; 970-972.
19. Irving JA, Lerwill MF, Young RH. Gastrointestinal stromal tumors metastatic to the ovary: a report of five cases. Am. J. Surg. Pathol. 2005; 29; 920-926.
20. Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod. Pathol. 2001; 14; 465-471.
21. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod. Pathol. 2000; 13; 1134-1142.
22. Brodsky SV, Gimenez C, Ghosh C, Melamed M, Ramaswamy G. Estrogen and progesterone receptors expression in gastrointestinal stromal tumors and intramural gastrointestinal leiomyomas. Int. J. Gastrointest. Cancer 2006; 37; 129-132.
23. Kimura W, Ma J, Takeshita A et al. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis. Hepatogastroenterology 2007; 54; 2203-2208.
24. Preto A, Moutinho C, Velho S et al. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation. Virchows Arch. 2007; 450; 619-626.
25. Paal E, Miettinen M. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas. Am. J. Surg. Pathol. 2001; 25; 1355-1363.
26. Butnor KJ, Burchette JL, Robboy SJ. Progesterone receptor activity in leiomyomatosis peritonealis disseminata. Int. J. Gynecol. Pathol. 1999; 18; 259-264.
27. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am. J. Surg. Pathol. 2005; 29; 1373-1381.
28. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am. J. Surg. Pathol. 2006; 30; 477-489.
29. Espinosa I, Lee CH, Kim MK et al. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am. J. Surg. Pathol. 2008; 32; 210-218.